Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392)
SSE
Closed
Sep 18, 2026
Day's Range
25.0552 wk Range
24.70Overview - 603392 - Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
Key Statistics
Valuation
Enterprise Value
30.63B
P/E (Trailing)
‪826.25‬
P/E (Forward)
‪46.10‬
PEG Ratio
‪46.10‬
Price / Sales (TTM)
‪16.41‬
Price / Book
‪2.83‬
EV / EBITDA
‪-77.64‬
Profitability
Gross Margin
‪57.98%‬
Profit Margin
‪-18.90%‬
Operating Margin
‪-23.02%‬
Return on Assets
‪-3.10%‬
Return on Equity
‪-3.31%‬
Ownership
Shares Outstanding
1.26B
Float
261.21M
Held by Insiders
‪82.08%‬
Held by Institutions
‪3.31%‬
Price stats
Beta
‪0.73‬
50-Day Avg
‪29.23‬
200-Day Avg
‪37.29‬
Dividends
Payout Ratio
‪0.00%‬
Frequency
Annual
Analyst Consensus
1 analysts
Market Cap - 603392 - Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
Peers - 603392 - Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
Peer Comparison
Compared with companies in Biotechnology listed on SSE.
Profile Summary - 603392 - Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
About
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is a leading player in the biopharmaceutical industry, focusing on the research, development, manufacturing, and marketing of innovative healthcare solutions. The company's primary function is to provide advanced diagnostic products and vaccines that address…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
